Medical articles today

/* 728x15, */

A Drug Used To Treat Type 2 Diabetes Is Associated To Increased Risk Of Heart Failure

A study just published on bmj.com reports that rosiglitazone, a drug used to treat type 2 diabetes, is linked with an increased risk of heart failure and death among elder patients compared to pioglitazone, which is a similar drug. As a result, the researchers point out it is questionable to support continued use of rosiglitazone for the majority of patients. Rosiglitazone and pioglitazone are part of a group of drugs called thiazolidinediones. They are commonly used for the treatment of type 2 diabetes. They are useful in controlling blood sugar levels. However, both drugs can also cause side effects including weight gain, fluid retention and heart failure.

New Events For Children And Young People With Diabetes, UK

The Diabetes UK Care Events team is adding to its already extensive events programme this Autumn by launching a new Children's Weekend and a new Young Adults Weekend. Diabetes UK has been running children's events for 65 years and is launching these new programmes to offer more people with diabetes a safe and enjoyable holiday experience. Young Adults Weekend The Young Adults Weekend from 6 to 8 November will be held at the Sachas Hotel in the centre of Manchester, giving 18 to 25 year olds the opportunity to explore topics such as discrimination, access to healthcare professionals, work and employment, university, pregnancy, driving and the issues around sex and relationships that can arise when living with diabetes.

/* 468x60, */

Practice Nurse Needed For Healthcare Delivery Working Group, Diabetes UK

Diabetes UK's Healthcare Delivery Working Group is looking for a practice nurse who is also a Diabetes UK professional member to join the group. The Healthcare Delivery Working Group was set up to encourage high-quality, culturally sensitive, patient-focused care for people with diabetes, as well as focusing on psychological care, education, and quality implementation of practice. "This is a superb opportunity for anyone who is considering getting more involved with the charity's work with healthcare professionals in order to make a difference to the care of people with diabetes, " said David Bryant, Professional Groups Co-ordinator at Diabetes UK.

Healthy Lifestyle Reduces Risk Of Chronic Conditions

Researchers at the Centre for Disease Control and Prevention in Atlanta studied data from 25, 513 adults aged 35 to 65. They found that never smoking, having a body mass index lower than 30, doing physical activity for at least three and a half hours per week, and following a healthy diet, reduce the risk of developing Type 2 diabetes by 93 percent. These four factors also showed 81 percent reduced risk of heart attack, 50 percent reduced risk of stroke and 36 percent reduced risk of cancer. "This research confirms what we already know - a healthy lifestyle and maintaining a healthy weight is the key to reducing the risk of long term health conditions such as Type 2 diabetes, " said Pav Kalsi, Care Advisor at Diabetes UK.

One Year On: Survey Of GP Opinion On The Impact Of NICE Guidelines On CHD Risk, UK

One year after the publication of the NICE Lipid Modification (CG67) and Type 2 Diabetes (CG66) Guidelines, a new survey of 400 UK healthcare professionals, conducted by TNS Healthcare UK and sponsored by Merck Sharp & Dohme Limited and Schering-Plough Limited has revealed that the majority of GPs recognise the important role played by these guidelines in reducing the level of coronary heart disease (CHD) risk among UK patients over the last year. Of the GPs surveyed (n=100), over half (57%)3 reported that the NICE Lipid Modification Guideline has played an important role in reducing the level of CHD risk among UK patients over the past year and up to two thirds (66%)3 felt that the Type 2 Diabetes Guideline has played the same role.

/* 468x60, */

American Podiatric Medical Association Corrects President's Misstatement On Foot Amputation Costs

The cost of doctors performing lower-limb amputations for people with diabetes has been misconstrued during recent health care reform discussions, according to the American Podiatric Medical Association (APMA), the nation's leading professional organization of doctors of podiatric medicine (DPMs), also known as podiatrists. According to a study published in 2007 in The Journal of the American Podiatric Medical Association (JAPMA), the overall estimated cost of a lower-leg amputation can range from $30, 000 to $40, 000, which includes fees for hospital stays, medical specialists, post operative care and physician reimbursement. While making a case for health care reform last week, President Obama inaccurately attributed that cost solely to physician reimbursement.

Rocket: [100]
/* 160x600, */
Medical articles today © Padayatra Dmitriy
Designer Dimitrov Dmytriy